EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 92010E004286
Written question E-4286/10 Yannick Jadot (Verts/ALE), Carl Schlyter (Verts/ALE), Christian Engström (Verts/ALE), Sandrine Bélier (Verts/ALE), Karima Delli (Verts/ALE) and Oriol Junqueras Vies (Verts/ALE) to the Commission. Does ACTA undermine delinkage of medicine prices and R & D costs?
Pregunta escrita E-4286/10 Yannick Jadot (Verts/ALE), Carl Schlyter (Verts/ALE), Christian Engström (Verts/ALE), Sandrine Bélier (Verts/ALE), Karima Delli (Verts/ALE) y Oriol Junqueras Vies (Verts/ALE) a la Comisión. ¿Merma el ACTA la desvinculación de los precios de los medicamentos y los costes en I+D?
Pregunta escrita E-4286/10 Yannick Jadot (Verts/ALE), Carl Schlyter (Verts/ALE), Christian Engström (Verts/ALE), Sandrine Bélier (Verts/ALE), Karima Delli (Verts/ALE) y Oriol Junqueras Vies (Verts/ALE) a la Comisión. ¿Merma el ACTA la desvinculación de los precios de los medicamentos y los costes en I+D?